Sequential changes in compliance and resistance after bolus administration or slow infusion of surfactant in preterm infants

Intensive Care Medicine

Volumn 28, Issue 5, 2002, Pages 622-628

  Hentschel, R ^a   Brune, T ^b   Franke, N ^a   Harms, E ^b   Jorch, G ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Adverse effects; Infant premature; Lung function measurement; Pulmonary gas exchange; Pulmonary surfactants; Respiratory distress syndrome

Indexed keywords

ALVEOCACT; LUNG SURFACTANT;

ARTERIAL OXYGEN TENSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INFUSION; EXHALATION; GAS EXCHANGE; GESTATIONAL AGE; HEMODYNAMICS; HUMAN; INFANT; LUNG COMPLIANCE; LUNG FUNCTION; LUNG RESISTANCE; NEONATAL RESPIRATORY DISTRESS SYNDROME; OXYGENATION; PILOT STUDY; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; UNIVERSITY HOSPITAL;

AIRWAY RESISTANCE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INSTILLATION, DRUG; LUNG COMPLIANCE; PILOT PROJECTS; PROSPECTIVE STUDIES; PULMONARY GAS EXCHANGE; PULMONARY SURFACTANTS; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY; RESPIRATORY MECHANICS; STATISTICS, NONPARAMETRIC;

EID: 0036263830     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-002-1277-7     Document Type: Article

References (40)

1. Principles of surfactant replacement
2. Distribution of surfactant and ventilation in surfactant-treated preterm lambs
3. Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by the instillation technique
4. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome
5. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome
6. Cerebral blood flow velocity after surfactant instillation in preterm infants
7. Acute changes in cerebral oxygenation and cerebral blood volume in preterm infants during surfactant treatment
8. Cerebral and aortic blood flow velocity patterns in preterm infants receiving prophylactic surfactant treatment
9. Cerebral blood flow velocity changes after rapid administration of surfactant
10. Instillation rate effects of Exosurf on cerebral and cardiovascular haemodynamics in preterm neonates
11. Acute effects on systemic and pulmonary hemodynamics of intratracheal instillation of porcine surfactant or saline in surfactant-depleted newborn piglets
12. Cerebroelectrical depression following surfactant treatment in preterm neonates
13. Relationship between mean airway pressure, cardiac output, and organ blood flow with normal and decreased respiratory compliance
14. Exogenous surfactant therapy increases static lung compliance, and cannot be assessed by measurements of dynamic compliance alone
15. Early changes in lung function and response to surfactant replacement therapy
16. Changes in pulmonary mechanics after the administration of surfactant to infants with respiratory distress syndrome
17. The impact of surfactant replacement therapy on cerebral and systemic circulation and lung function
18. Immediate effects on lung function of instilled human surfactant in mechanically ventilated newborn infants with IRDS
19. The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease
20. Static respiratory compliance in the newborn. III. Early changes after exogenous surfactant treatment
21. Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease
22. Rapid improvement of static compliance after surfactant treatment in preterm infants with respiratory distress syndrome
23. Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: A comparison between two surfactant preparations
24. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant
25. Immediate improvement in lung volume after exogenous surfactant: Alveolar recruitment versus increased distention
26. Changes of respiratory system mechanics in ventilated lungs of preterm infants with two different schedules of surfactant treatment
27. Respiratory distress syndrome and intracranial hemorrhage: Cause or association? Inferences from surfactant clinical trials
28. Controversies: Synthetic or natural surfactant treatment for respiratory distress syndrome? The case for synthetic surfactant
29. Trends in mortality and cerebral palsy in a geographically based cohort of very low birth weight neonates born between 1982 to 1994
30. Outcomes of extremely low birth weight infants
31. Antecedents of cerebral palsy in a multicenter trial of indomethacin for intraventricular hemorrhage
32. Randomized trial examining cerebral haemodynamics following artificial or animal surfactant
33. Cerebral hemodynamic and EEG effects of treatment with natural versus synthetic surfactant
34. Lung mechanics and gas exchange in ventilated preterm infants during treatment of hyaline membrane disease with multiple doses of artificial surfactant (Exosurf)
35. A randomized comparison of surfactant dosing via adual-lumen endotracheal tube in respiratory distress syndrome
36. Aerosolized surfactant treatment of preterm lambs
37. Lung mechanics, histomorphology and immunohistologic alterations in the lungs of 27-day-old prematurely delivered rabbit fetuses after surfactant replacement
38. Surfactant nebulization versus instillation during high frequency ventilation in surfactant-deficient rabbits
39. Surfactant nebulisation prevents the adverse effects of surfactant therapy on blood pressure and cerebral blood flow in rabbits with severe respiratory failure
40. Surfactant nebulisation: Lung function, surfactant distribution and pulmonary blood flow distribution in lung lavaged rabbits